 |
|---|
CardioComm Solutions Inc. Signs Distribution Agreement with the U.S. Leader in end-to-end Cardiovascular Information Systems
|
VICTORIA, B.C., May 5, 2005 - CardioComm Solutions Inc. (TSX-V:CCG) (the "Company", "CardioComm"), is pleased to announce that it has signed a U.S. distribution agreement with Lumedx Corporation ("LUMEDX") .
The agreement enables LUMEDX to add CardioComm's GEMST Arrhythmia, Pacing and ICD software, as well as its newly showcased GlobalCardioT as a complement to its main product line. LUMEDX has a strong direct sales presence across the US , as well as a successful inside sales force, all of which is expected to add significantly to CardioComm's U.S. sales.
Both companies recognize the benefits of their collaboration, as historically LUMEDX and CardioComm have already cooperated on the development of an HL7 interface between their products, thus enabling bi-directional exchange of information between the systems.
Founded in 1990, LUMEDX is the market leader in developing end-to-end cardiovascular information system solutions. Providing consulting services, training, and the CardioStar software suite, LUMEDX delivers complete clinical and business solutions for heart centers.
Stephen R. Martin, President & CEO of CardioComm remarked, "This agreement is a great stride forward in our drive to market our product to major cardiac standards, LUMEDX has over 300 customers across the U.S. that are now potential clients for our products. Our two companies will continue to enjoy the expansion of this working relationship."
According to Allyn McAuley, CEO of LUMEDX Corporation, "The CardioComm relationship will assist us in providing our customers with a comprehensive solution in the cardiac rhythm management environment. Our goal is total workflow management, including scheduling, billing capture, inventory control, automated physician reporting, image review, and outcomes analysis. The GEMS Ô system will allow us to incorporate detailed long term care information on rhythm management patients."
About Lumedx Corporation:
During the past 15 years, Lumedx has assisted more than 300 heart centers worldwide in building powerful integrated solutions. As the No. 1 independent cardiovascular systems integrator, LUMEDX's software, services, and analytics help medical institutions enhance the quality of patient care, streamline workflow, increase patient volumes, reduce costs, and grow revenues.
About CardioComm Solutions Inc:
CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMST) and GlobalCardioT. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.
|
On behalf of the Board of Directors of CardioComm Solutions Inc.:
“Stephen Martin”
Stephen R. Martin, President & CEO
For investor information, please contact: Stephen Martin |
